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Genetic algorithmUsing gene expression data in cancer classiﬁcation plays an important role for solving the fundamental problems
relating to cancer diagnosis. Because of high throughput of gene expression data for healthy and patient samples,
a variable selection method can be applied to reduce complexity of the model and improve the classiﬁcation
performance. Since variable selection procedures pose a risk of over-ﬁtting, when a large number of variables
with respect to sample are used, we have proposed amethod for coupling data dimension reduction and variable
selection in the present study. This approach uses the concept of variable clustering for the original data set.
Signiﬁcant components of local principal component analysis models have just been retained from all clusters.
Then, the variable selection algorithm is performed on these locally derived principal component variables.
The proposed algorithm has been evaluated on two gene expression data sets; namely, acute Leukemia and
small round blue-cell tumor (SRBCT). Our results conﬁrmed that the classiﬁcation models achieved on the
reduced data were better than those obtained on the entire microarray gene expression proﬁle.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Cancer research is one of the most important research areas in the
medical sciences. A correct prediction of different tumor types has no-
ticeable value in providing better treatment and toxicity minimization
on the patients. The early diagnosis of cancer can signiﬁcantly reduce
mortality rates among the patients [1]. On the other hand cancer classi-
ﬁcation and detection have always been morphological and clinical
based while using conventional methods have own several restrictions
in their diagnostic ability [1]. In order to increase a better insight into the
problem of cancer classiﬁcation, systematic approaches based on global
gene expression analysis have been proposed [2]. One of the good
criteria in cancer detection is the expression level of genes. This
phenomenon contains the keys to address fundamental problems relat-
ing to the inhibition and treatment of diseases, biological evolution
mechanisms and drug discovery.
The recent advent of microarray knowledge has assisted the scien-
tists to quickly measure the levels of thousands of genes expressed in a
biological tissue sample just in a single experiment [3–7]. This kind of
data has some properties. One of theirmain characteristics is thatmicro-
array studies often generate massive amounts of data (usually contains
tens to thousands of genes), which are difﬁcult to be exhaustively@pgu.ac.ir (S. Karimi).examined by hand. Therefore bioinformatics analysis and interpretation
are essential to extract genetic patterns from these data for gaining bio-
logical insights from experiments [8]. The second characteristic is related
to the publicly available data size which is very small; for example some
data have sizes below 100 samples. This subject led to small sample size
problem (the ratio of variable to sample is high). In this condition, the
classiﬁcationmethods such as LDA have a tendency to show over-ﬁtting
result [9]. Finally, most of genes are irrelevant to cancer distinction and
should be discarded or removed.
On the other hand, the rise of chemometrics as an important sub-
discipline of analytical measurement science results in providing
powerful multivariate data analysis. In addition, rapid growth of analyt-
ical instrumentation produces huge data set. Consequently, applying
chemometric methods in the analysis of these huge data leads to
extraction of more information.
Interestingly, a similar revolution has also occurred in biological
sciences resulting from new measurement technologies in the last two
decades and subsequently the need for the effective data analysis tools
such as chemometric methods has been increased. For instances, differ-
ent classiﬁcation methods from statistical and machine learning area
have been applied to cancer classiﬁcation, but there are some issues
that make it difﬁcult to perform. For example, it is evident that these
conventional classiﬁcation methods have not been designed to handle
this kind of data efﬁciently and effectively. Some researchers proposed
to do the gene selection prior to cancer classiﬁcation [10–14] to reduce
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running time. Signiﬁcantly, gene selection removes a large number of
irrelevant genes and results in better classiﬁcation accuracy [15].
In the present study, due to the important role of removing unneces-
sary genes or factors which are irrelevant for cancer classiﬁcation, we
have suggested the new strategy based on local data dimension reduc-
tion with variable selection method for analyzing the gene expression
data set. In this approach, clusters of the original variable concept are
used to cluster the gene value and only signiﬁcant components are
retained, which is similar to segmented principal component analysis
and regression (SPCAR) [16,17]. Finally, a variable selection algorithm
(GA) combined with LDA is performed on those locally derived princi-
pal component variables instead of whole original data.
2. Theory
2.1. Linear discriminant analysis (LDA)
The LDA is one of themost used traditional classiﬁcation techniques
[18]. The method is a probabilistic parametric classiﬁcation technique
which performs dimensionality reduction by maximizing the variance
between categories and minimizing the variance within categories.
The classiﬁcation index (discriminant function) is based on the Bayes
minimum error rule, i.e. samples are classiﬁed into the class with the
maximum a-posteriori probability and LDA makes the assumption
that the classes have identical covariance matrices and ﬁts a multivari-
ate normal density to each group with a pooled estimate of the covari-
ance. Since a pooled covariance matrix is calculated, the number of
objects must be greater than the number of variables. In the other
words when the number of variables is exceeded the number of
samples, the LDA classiﬁers does not work [19], i.e. on the percentage
of correctly assigned samples, evaluated both on cross-validation
groups and external test samples.
2.2. Kohonen self-organizing map
Self-organizing map (SOM) [20] is from the category of artiﬁcial
neural network (ANN) algorithms that uses unsupervised learning to
create a two dimensional representation of training samples. This two
dimension representation which is called map consists of components
called nodes or neurons. Accompanying with each neuron, there is a
weight vector with the same dimension as the input vectors in the
map space. The interesting feature of SOM algorithm that distinguishes
it from other artiﬁcial neural networks is the use of a neighborhood
function. During the training step, the Kohonen network adjusts itself
in such a way that similar input (here, gene value) is associated with
the topological close neuron in the network. The arrangement of
neurons is in two dimensions in a hexagonal or rectangular space,
with size (p × p) where p is a deﬁned network sizes.
Themappingprocedure is used toﬁnd theneuron in the created net-
work with the closest weight vector to the input vector. The most sim-
ilar neuron (small distance metric with input vector) has been selected
as a winner. Then, the neighbor neurons (in the ﬁrst and second neigh-
borhood) also adjust their weights with respect to the winner neuron.
Changes in neighboring neuron depend on the neighborhood function.
As a result, when the process is completed, similar input vectors (gene
values) are clustered in the space, based on their similarities. It should
be noted that we have applied SOM to cluster the gene values not the
objects. Hence, the variables in the original data matrix, including simi-
lar information, are mapped into one node or neighboring nodes. The
variables in each node can be collected to form a sub-matrix Di.
2.3. GA-LDA based on SOM
In some cases, we deal with data sets included many variables. For
analysis (multivariate calibration and classiﬁcation) of such data sets,we should careful about over-ﬁtting problem. Although variable selec-
tion methods have been proposed for the aforementioned problem,
but these methods (genetic algorithm, GA, and forward selection) are
not appropriate solution when the number of variables is too large.
Related to this issue, Ballabio and co-workers [21] have explained
that, GA algorithm results in severe over-ﬁtting or non-optimal solu-
tions when the huge number of variables exists. Thus, they have sug-
gested that a reduction of data dimension can be useful when dealing
with high-dimensional data (MALDI–MS or GC–MS) in which the
chemical rank is well below the dimension of the data.
In the present study we faced with the same problem of high
dimensional data namely gene expression data set. With this aim, an
efﬁcient algorithm for the extraction of signiﬁcant features from high-
dimensional data has been proposed. First, the variables (gene values)
have been clustered using Kohonen self-organizing map as clustering
algorithm. Subsequently, PCA [22] has been applied on each cluster of
the original gene expression proﬁle, similar to the characteristics of
the SPCAR algorithm [16,17]. Then, the original data set has been trans-
formed into a new data set of which their columns are signiﬁcant prin-
cipal components retained from these local clusters. Finally; the speciﬁc
PC selection algorithm combined with classiﬁcation methods can be
used for analysis this reduced data set.
Suppose we have a data matrix (D) with I rows (the samples) and J
columns (the gene value). The data dimension reduction can be illus-
trated using the subsequent steps:
1- In the ﬁrst part, the whole gene expression value has been
partitioned in q cluster using Kohonen self-organizing map (SOM).
Thus, the gene values have been clustered in a different sub-matrix
(Di) according to their similarities in information.
D ¼ D1½  D2½ … Dq
h ih i
ð1Þ
2- In the next step, in order to calculate the principal components and
loading of each cluster, PCA can be applied in each sub-matrix (Di)
separately. It should be noted that different preprocessing algo-
rithms (depending on the type of data) can be used for each cluster.
Di ¼ TiPTi i ¼ 1 : q ð2Þ
The matrices Ti and Pi are the principal components and loadings of
the each cluster (Di) respectively. The superscript “T” indicates the
matrix transpose notation.
3- In this step, the most important of PCs and corresponding loadings
form each cluster should be selected. Different strategies can be con-
sidered for this screening. In the present study, explained variance
(EV) and root mean square error of cross-validation (RMSCV) have
been used as criteria to select themost signiﬁcant PCs in each cluster.
For explained variance criterion, the PCs of which their explained
variances are higher than the speciﬁc value (95%) have been kept.
By substitution of Eq. (2) into Eq. (1) we obtain:
Dr ¼ T1PT1
h i
T2P
T
2
h i
… TqP
T
q
h ih i
: ð3Þ
The T1 to Tq and P1T to PqT are the PCs and loadings obtained from
different sub-matrices (Di).
The new data set, Dr, which we called reduced data matrix, consists
of all the obtained PCs from different clusters. Obviously the dimen-
sions of Dr is (I × r), where I is the number of samples and r is the
total number of principal components obtained from previous step.
Eq. (3) indicates that one can be able to separate the PCs and load-
ings of different clusters. If we have just rearranged Eq. (3), a new
possibility can be obtained (Eq. (4)).
Dr ¼ T1T2…Tq
h i
V ð4Þ
Table 1
Setting of genetic algorithm (GA) parameter.
Parameter Value
Population size 150
Cross-over 50%
Mutation probability 1%
Number of generation 200
Selection rule Roulette wheel
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application on whole microarray gene expression data. In the other
words,
D ¼ TPT : ð5Þ
Now these PCs and loadings (T and P matrices) come from the orig-
inal D-matrix, respectively. By comparison, Eqs. (4) and (5) indicate
that:
T ¼ T1T2…Tq
h i
and PT ¼ V: ð6Þ
However, as it is evident from Eq. (4) the principal components have
been extracted from different clusters while those in Eq. (5) have
been obtained from whole microarray gene expression data of D.
The V matrix in Eq. (4) contains the loading vectors P1
T–Pq
T in its
diagonal and zero values in other positions:
V ¼
PT2 0 … 0
0 PT2 … 0
… … … …
0 0 … PTq
2
6664
3
7775:
Obviously the number of columns in V is equal to the number of
columns in the original D matrix and the number of rows in V is
equal to the sum of extracted signiﬁcant PCs from the clusters.
By this approach, three main purposes have been obtained. The ﬁrst
one is that the most information of original data matrix has been
maintained. The second one, which is the most important, is that
the dimension of data has been reduced. Lastly, the information in
the PCs of original data set has been divided into different parts.
4. Similar to what is done in conventional LDA [23], the classiﬁcation
score for training sample (xi) is deﬁned as:
classification score xið Þ ¼ xi−μkð Þ
X−1
pooled
xi−μkð Þ−1: ð7Þ
∑ pooled−1 , is the inverse of class covariancematrix, and μk is the mean
vector of class k.
It is worthy to mention again that, for an ill-condition situation
which the number of variables is higher than the number of objects,
the estimations of the class covariance matrix become highly uncer-
tain, which is not true in our case.
5. The reduced data (Dru), for prediction step [17], where the columns
are PC variables (tu), can be constructed as:
tu ¼ t1ut2u…tqu
h i
¼ DuVþ: ð8Þ
The superscript ‘+’ denotes the matrix pseudo-inversion.
Two important issues must be considered in this algorithm: the ﬁrst
one is the type of clustering algorithms and the second ones is the
cluster size (q). Related to ﬁrst one, we have recently compared the
ﬁve clustering algorithms such as, PCA (loading plot), K-means, Fuzzy-
c-mean, hierarchical and Kohonen self-organizing map (SOM) on the
efﬁciency of SPCAR algorithm [24]. Different data sets have been ana-
lyzed and the statistical parameter demonstrated that using nonlinear
clustering such as SOM has superiority with respect to other clustering
algorithms [24]. The cluster size (q) should be optimized by trial and
error thus all classiﬁcation models have been performed on any net-
work size and the obtained results have been compared for their predic-
tion abilities. The performance evaluation of the each cluster size form
LDA classiﬁcation models which has been used based on Not-ErrorRate (NER) values, evaluated both on cross-validation groups and exter-
nal test samples. The validation of the presented classiﬁcationmodels is
based on leave many out (LMO) cross-validation (1/5 being excluded
during each run).
As it is noted previously, the PCs of different clusters and corre-
sponding loadings can be considered as explanatory and redundant
one for classiﬁcation. Obviously the second ones degrade the calibration
and prediction ability of classiﬁcation methods, thus the useful PCs
which can improve the classiﬁcation model should be extracted. This
can be done by applying the PC selection algorithm such as genetic algo-
rithm (GA) on the reduced data set (Dr). We do not confront with any
problem using GA, because the number of variables (PCs) is decreased
and the extracted PCs are not highly collinear. For any network size of
SOM, the classiﬁcationmodels have been constructed based on selected
PCs and statistical parameters have been used to compare the network
sizes.
Genetic algorithms [25], the approach used in this paper is described
by Leardi and Lupianez Gonzalez in PLS regression [26], however the
basic difference is that GAs are coupled directly with LDA [27] to
improve the power of the classiﬁcation algorithm. The selection of
variables is performed by repeating GAs, t times and then including
the variables on the basis of the frequencies of selection. All the setting
parameters for GA are listed in Table 1.
In the current study, useful PCs have been selected on the basis of
NER values as a function of the number of selected PCs. Finally, it should
be noted that the basic idea of GA-LDAbased on SOM is similar to SPCAR
[17] but it is used in classiﬁcation problem. Moreover with this strategy
the aforementioned problem of LDA and GA in the huge data can be
solved.3. Description of data experimental data sets
Two gene expression data sets are used in this work in order to
show the efﬁciency of the proposed algorithm. The data sets are acute
Leukemia [28] and SRBCT [29]. The description of the data sets is
given as follows: The ﬁrst one comprises of DNA microarray gene ex-
pression data of human acute Leukemia for cancer classiﬁcation. Two
types of acute Leukemia data are provided for classiﬁcation namely
acute lymphoblastic Leukemia (ALL) and acute myeloid Leukemia
(AML). In accordance with Golub et al. [28] approach the data set has
been divided to 38 calibration and 34 prediction samples. The 38 bone
marrow samples in calibration set consist of 27 ALL and 11 AML, over
7129 gene value. The test set consists of 34 samples with 20 ALL and
14 AML, prepared under different experimental conditions. The second
data is the small round blue-cell tumor data set consists of 83 samples
with each having 2308 gene values. This is a four class classiﬁcation
problem that makes it more difﬁcult for analysis. The tumor samples
are Burkitt lymphoma (BL), the Ewing family of tumors (EWS), neuro-
blastoma (NB) and rhabdomyosarcoma (RMS). As suggested by Khan
et al. [29], the 63 samples which contain 8, 23, 12 and 20 from BL,
EWS, NB and RMS respectively, have been used for calibration set. The
test set has been composed of 20 samples which include 3, 6, 6 and 5
samples of BL, EWS, NB and RMS respectively. The compositions of cal-
ibration and prediction samples have been collected in Supplementary
Tables S1 and S2 for Leukemia and SRBCT data sets.
(a) (b)
Fig. 1. Distribution pattern of the Leukemia samples in the two-dimensional PCA-based factor space of their gene expression microarray data: (a) whole microarray gene expression
variables. (b) Selected PCs used in the LDA for network size (q=5). Acute myeloid Leukemia (○,●) (AML), acute lymphoblastic Leukemia (□,■) (ALL). Filled and openmarkers denote
calibration and prediction samples, respectively.
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Data analyses have been performed in a MATLAB environment
(MathWorks, Inc., Natick, MA, USA, version 7.2). GA-LDA is based on
GA-PLS of Leardi which is modiﬁed for classiﬁcation problem by him.
The LDA classiﬁcation and Kohonen self-organizingmap toolboxes pro-
vided by Ballabio were downloaded for free from the website of Milano
Chemometrics and QSAR research group (http://michem.disat.unimib.
it/chm/download/kohoneninfo.htm).
3.2. Preprocessing
Prior to principal component extraction form each cluster, gene
expression proﬁles of each cluster were subjected to normalized
preprocessing.
4. Results and discussion
4.1. PCA overview of acute Leukemia
To get an overview of the data, the calibration data set of 38 training
samples was applied to the extracted PCs and then those PCs were used
to analyze 34 test samples. A plot of the ﬁrst two principal components,Table 2
Statistical parameters of the GA-LDA based dimension reduction models obtained from differe
Number of segments
(Kohonen nodes)
NEPC
a NSPC
b NERcalc NERvald
4 (2 × 2) 30 3 0.89 0.80
9 (3 × 3) 43 3 0.95 0.91
16 (4 × 4) 54 3 1.0 0.95
25 (5 × 5) 85 5 1.0 1.0
36 (6 × 6) 127 5 1.0 1.0
49 (7 × 7) 133 4 1.0 0.90
64 (8 × 8) 141 4 0.98 0.90
a Number of the extracted PCs from all clusters.
b Number of selected PCs.
c Not error rate for calibration set.
d Not error rate for validation.
e Not error rate for prediction set.
f Not error rate based on repeated double cross-validation for calibration set.
g Not error rate based on repeated double cross-validation for validation set.
h Not error rate based on repeated double cross-validation for prediction set.accounting for 91.27% of the original variance, is shown in Fig. 1a. This
picture indicates the relative position of studied samples with respect
to each other based on the similarity between their gene expression
microarray data. Sincemost of variations are unrelated to class informa-
tion, more extraction of PCs is not useful. There is no evidence of sepa-
ration between the two classes along the two principal components
and there is a large degree of overlapping between classes. In the
other words, the PCA model has no practical value in this subject.
However, by clustering of variable concept before application of PCA
on whole variables, better class separation has been observed in two-
dimensional spaces of factor scores. In Fig. 1b one representative plot
is shown. The scores of this plot have been calculated from the best net-
work size of Leukemia data set (q=5). In comparisonwith convention-
al PCA plot (Fig. 1a), much better separation of classes is observed. In
otherwords, obtained PCs and corresponding loadings (gene variables),
possess better information regarding the Leukemia biomarkers.4.2. GA-LDA based on SOM: PC selection and classiﬁcation
4.2.1. Data set 1 (acute Leukemia)
The gene expression of Leukemia data matrix is composed of 7129
variables. However, not all parts of the presented gene value have useful
information about the class of samples. In this case, we have considerednt clusters (nodes of the Kohonen network): Leukemia data set.
NERpree NERrdCV,calf NERrdCV,valg NERrdCV,preh
0.75 0.89 0.85 0.83
0.84 0.92 0.93 0.90
0.91 0.97 0.96 0.92
0.94 0.98 0.97 0.97
0.90 0.97 0.97 0.92
0.86 0.97 0.92 0.88
0.80 0.96 0.92 0.85
Table 3
Sensitivity (Sn)a and speciﬁcity (Sp)b achieved by different cluster size for proposed algorithm.
(2 × 2) (3 × 3) (4 × 4) (5 × 5) (6 × 6) (7 × 7) (8 × 8)
CVc Test CV Test CV Test CV Test CV Test CV Test CV Test
Speciﬁcity 0.82 0.75 0.82 0.79 0.91 0.83 1.0 0.93 1.0 0.86 0.90 0.84 0.81 0.78
Sensitivity 0.93 0.89 1 0.90 1.0 0.90 1.0 0.95 1.0 0.88 0.83 0.78 0.80 0.75
a Class sensitivity (Sn) describes the model ability to correctly recognize samples belonging to the gth class, i.e. if all the samples belonging to g are correctly assigned, Sn is equal to 1.
b Class speciﬁcity (Sp) describes the model ability to reject samples of all the other classes from class gth, i.e. if samples not belonging to g are never assigned to g, Sp is equal to 1.
c Cross-validation.
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ALL) which is well below than the dimension of data. Thus, GA cannot
handle this high dimensional data set. In the ﬁrst step of our proposed
algorithm, Kohonen SOM is employed to cluster gene value based on
their similarity. One of the signiﬁcant features of SOM is the optimiza-
tion of the number of Kohonen nodes. Each n-node SOM model pro-
duces (n × n) cluster of variables. Thus, the number of clusters (q)
produced by each SOMmodel is equal to n2. The variables in each cluster
are considered as one cluster of variables which have similar informa-
tion. Each cluster can be described as Si,j, where i and j are row and col-
umns of clusters in Kohonen map, respectively. Seven SOM networks
with the node sizes of 2 to 8 were checked. The distribution pattern of
variables in the (5 × 5) SOM network is presented in Fig. S1. This ﬁgure
reveals that the distribution pattern of the gene values by clustering al-
gorithms (SOM) is not homogeneous. This is an inherent property of
clustering algorithms. In some clusters (such as S2,4, S3,3, S3,4, S4,3 and
S5,4) a high population of gene values is observed, whereas some others
such as S4,4 and S4,5 contain few numbers of genes. Each cluster is
subjected to PCA separately and the meaningful PCs and loading are
extracted using mentioned criteria. According to Eq. (4) and LDA algo-
rithm, the extracted PCs of all clusters were linearly related to the
class information of the training set by genetic algorithm PC selection.
Table 2 lists the statistical classiﬁcation parameters of the models
obtained from different number of clusters through Kohonen SOM
method. This table also includes the number of total PCs which are ex-
tracted from the submatrices (NEPC) and the number of PCs selected in
the ﬁnal LDA model (NSPC) using genetic algorithm. One of the impor-
tant issues in GA-LDA based on SOM is selection of the best model. As
we discussed in our previous publications [16,17] by considering the
higher number of cluster size, the statistical parameter of calibrationTable 4
Biological meaning gene selected using GA-LDA based SOM from Leukemia data set.
Code ID Gene description
IOTA X59417 Proteasome iota chain
CCND3 M92287 Cyclin D3
ACADM M91432 Acyl-coenzyme A
hSNF2b U29175 Transcriptional activator
MCM3 D38073 Minichromosome maintenance
Op18 M31303 Oncoprotein
FAH M55150 Fumarylacetoacetate
LYN M16038 Yamaguchi sarcoma viral related oncogene
homolog
CD11-c M81695 Integrin alpha
Epb72 X85116 Gene exon
LEPR Y12670 Leptin receptor
AARS D32050 Alanyl-tRNA synthetase
IGB M89957 Immunoglobulin-associated
NM23 Y07604 Nucleoside-diphosphate kinase
VIL2 X51521 Villin
MACMARCKS HG1612 Macmarcks
DAGK1 X62535 Diacylglycerol kinase
ESP-2; HED-2 X95735 Zyxin
PKM2 X56494 Pyruvate kinase
CD53 M37033 Antigen
SAT M24485_s Spermidine/spermine N1-acetyltransferase
HMG-I L17131_rna1 High mobility group AT-hook 1and validation is increased but worse prediction statistics is obtained.
Description of this subject can be attributed to chance correlation phe-
nomena. By increasing the number of clusters, the number of extracted
PCs, and consequently, the ratio of the number of variables to the num-
ber of samples are increased. According to the recommendation of
Topliss and Edwards [30], by increasing this ratio (variable to sample)
the probability of getting a chance model is increased. Thus, both cali-
bration and prediction results have been considered for optimum
model selections. As it is evident from Table 2 the number of extracted
PCs is increased (from 30 to 141) when the number of clusters or
Kohonen nodes is increased (from 4 to 64). However, the number of se-
lected PCs remains relatively constant (3 to 5) and are independent of
the number of clusters. The Not Error Rate (NER) of calibration and
cross-validation statistics shown in Table 1 reveal that GA-LDA model
obtained from ﬁve Kohonen nodes (25 clusters) is the optimum one
for both calibration and prediction classiﬁcation ability. This 25-cluster
GA-LDA model which uses ﬁve PCs out of 85 extracted PCs, has very
high degree of correctly assigned sample (NER) 1.00, 1.00 and 0.94 for
calibration, cross-validation and prediction, respectively. The same con-
clusions can be reached by looking at Table 3. From the result of this
table, GA-LDA of network size 5 consistently yields higher values of
both speciﬁcity and sensitivity for cross-validation and test samples
with respect to other network sizes.
On the other hand, we need to a powerful validation method when
we deal with low number of individuals compared to the large number
of variables [31]. Consequently, sincewe have a small data set (especial-
ly in Leukemia), the obtained models also have been subjected to new
and efﬁcient validation method recently proposed by Varmuza et al.
[32], which is called repeated double cross-validation (rdCV). The
rdCV gives a more realistic estimation of the prediction performance
than do simple strategies with only a single split into calibration and
test sets. Because the algorithms repeated — typically 100 — of the
data into calibration and test sets, chance performance results are
avoided. In each repetition for estimation of the prediction performance
of obtainedmodel, eachmodel is validatedwith an independent test set.
Obviously depending on the number of repetitions, rdCV yields a largeFig. 2. Classiﬁcation using GA-LDA based on dimension reduction technique on acute
Leukemia data set. The markers are the same as described in Fig. 1.
Table 5
Performance of classiﬁer algorithms obtained with GA-LDA based dimension reduction
and without feature selection (Leukemia: two class problem).
LDA without feature
selection
CLoVA-GA-LDA in optimum
SOM network size
Cross-validation Test set Cross-validation Test set
Success rate 0.84 0.70 1.0 0.94
Speciﬁcity 0.76 0.75 1.0 0.93
Sensitivity 0.81 0.66 1.0 0.95
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measuring the prediction performance. The Leukemia data set was split
into training and external validation sets. Approximately 30% of the
samples was selected by the random sampling algorithm to be the
external validation set. Consequently, each test set consisted of 22 sam-
ples, whereas each calibration set comprised 50 samples. The statistical
parameters (NERcal,rdCV, NERval,rdCV and NERpre,rdCV) obtained from dif-
ferent GA-LDA based SOM models have been shown in the last three
columns of Table 2. The obtained results from rdCV procedure verify
the same trend in comparison with our previous result in leave many
out CV. Thus, the network size q= 5 has been selected as the best one
for both calibration and prediction ability.
The selected PCs are representative of the gene values that appeared
in these clusters. These genes values have information that is more
correlated with class information of our samples. In order to know
which subset of genes is more useful for classiﬁcation of the Leukemia,
the corresponding loadings of the selected PCs have been searched for
variables (genes) of the highest loading values and those detected are
shown in Table 4 for Leukemia data set.
Finally, the discriminant function plot of Kohonen network size q=
5 is given in Fig. 2. As it is evident, a clear separation between samples
from the LDA plot of this cluster size is observed. In other words, the
large difference between calibration and test set samples is related to
the efﬁciency of selected genes which are reported in Table 4 for
Leukemia data set.
The problemof small sample sizewith respect to the number of gene
values can be solved by generalized LDA [33]. In the generalized LDA,
pseudo linear function is used. To investigate the potential of the pro-
posed method, the LDA model has been built using the full set of the
original variables, and misclassiﬁcation rates are 84.0% and 70.0% for
the cross-validation and external test sets, respectively. The comparison
between LDA classiﬁcation results with and without feature selection
(Table 5) conﬁrms the superiority of our proposed algorithm. Finally,
Table 6 summarizes the statistical results (mean classiﬁcation accuracy)
of the proposed model with those of previously reported models for
Leukemia data set. As it can be seen in Table 6, GA-LDA based on
dimension reduction can providemodelswith prediction abilities better
than k-nearest neighboring (k-NN) and conventional classiﬁcation and
regression tree (CART)model. As discussed by Du et al. [34], using irrel-
evant or redundant genes variables by k-NN and CART, increase the risk
of over-ﬁtting of the classiﬁcation model. Thus, variable selection basedTable 6
Classiﬁcation results of Leukemia and SRBCT data sets using a GA-LDA based dimension reduct
Data set Leukemia
No. of genes Prediction accuracy
Training set
Method
k-NN 3571 NRa
CART 3571 0.9737
BSS/WSS-based CART 160 0.9737
UTISP based CART 21 0.9737
GA-LDA based on dimension reduction 22 1.000
a Not reported.on ranking the ratio of between classes sum of squares to within class
sum of squares (BSS/WSS) has been employed to select the relevant
variables in the Leukemia data set. As a consequence, a good calibration
model has been obtained, but the prediction of the model is very poor.
This subject indicates that the ability of BSS/WSS for identifying
signiﬁcation genes is restricted. Finally, the proposed GA-LDA based
dimension reduction method produces prediction accuracy similar
(somehow better than in calibration) to that of the novel variable
selection-multivariate calibration method (unimodal transform of vari-
ables selected by interval segmentation purity; UTISP-based CART) [34]
method; however the latter produces a more accurate prediction in test
set. Nevertheless, the mathematical description of UTISP-based CART is
complex with respect to GA-LDA based dimension reduction.
4.2.2. Data set 2 (small, round blue-cell tumors data, SRBCT)
The results of PCA application in the SRBCT samples are given in
Table S3. The PCA has been applied on whole region of microarray
gene expression data matrix and the results are presented for the ﬁrst
5 principal components (PCs). The eigenvalue (EV) of each PC, the
percent of variances in the data explained by each PC (PV) and the cu-
mulative percent of variances (CPV) are reported. Table S3 reveals
that the ﬁrst three principal components explain about 82.97% of the
total gene expression variations. In the other words by projecting
2308-gene value spectra into three-dimensional factor space, about
82.97% of information is retained. In accordance with Fig. 3a, a severe
overlapping among four classes is observed. Because PCA is an unsuper-
visedmethod the extracted PCs are calculated only from the datamatrix
(X), subsequently, they might be not necessarily the components rele-
vant for discrimination. Nevertheless, better separation of SRBCT classes
has been achieved by application of clustering of variable concept. As it
is shown in Fig. 3b, by applying the PCA on the PCs, which arose from
network size q = 2, one can see some degrees of improvement in the
scatter plot of PCs.
4.2.3. GA-LDA based on dimension reduction
As we mentioned about chemical rank in Leukemia data set, the
same assumption can be considered for SRBCT data set. In this case,
the chemical rank is four subtypes of SRBCT (BL, NB, RMS and EWS)
cancer. Thus, GA-LDAbased SOMhas been applied insteadof GA. Similar
to the Leukemia data set, the gene values have been clustered using
Kohonen SOM according to the similarity in the gene expression
information. The Kohonen nodes of 2 to 8 have been examined. The
GA-LDAmodels based ondimension reduction resulting from the differ-
ent cluster size are summarized in Table 7. It is noted that the GA-LDA
model of 2-node Kohonen network leads to the best NER of calibration,
cross-validation and prediction results. It has the NER of calibration,
cross-validation and prediction of 1.0, 0.930 and 0.970 respectively.
The same trend has been obtained based on repeated double cross-
validation analysis. The statistical parameters are found in the last
three columns of Table 7. This subject suggests that by dividing the
linear discriminant of the conventional LDA model (columns in the T
matrix) into the sub-score (T1–Tq sub-matrices), it becomes possibleion compared with those previously reported.
SRBCT [Ref]
No. of genes Prediction accuracy
Test set Training set Test set
0.8529 2308 NRa 0.7780 [34]
0.8529 2308 0.9422 0.7954 [34]
0.8235 160 0.9759 0.8443 [34]
0.9706 8 0.9459 0.9159 [34]
0.9421 55 1.000 0.9500 Our study
(a) (b)
Fig. 3.Distribution pattern of the SRBCT samples in the 2-dimensional PCA-based factor space of their gene expressionmicroarray data. (a)Wholemicroarray gene expression variables of
SRBCT data. (b) Selected PCs used in the LDA for network size (q=2). (○,●) RMS, (□,■) BL, (◊,♦) NB and (∇,▼) EWS: Filled andopenmarkers denote calibration andprediction samples,
respectively.
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and predictive models. Furthermore, the three dimension of discrimi-
nant function plot of (LDA) is depicted in (Fig. 4). It shows a good dis-
crimination among four classes of samples from the canonical plot of
network size q= 2. Also, the statistical parameters in Table S4 conﬁrm
the efﬁciency of proposed algorithm in predicting class variables of
SRBCT data set. However, the reported data in Table 4 explain that in
spite of signiﬁcant improvement in classiﬁcation accuracy achieved by
our proposed algorithm, the suggested model is associated with small
misclassiﬁcation errors due to the complexity of the investigated data
set. The comparison between the GA-LDA based on dimension reduc-
tion model for classifying different kinds of small, round blue-cell
tumors (SRBCTs) and the previously presented model is reported in
Table 6. The prediction accuracy provided by the proposed method is
higher than those of k-NN, CART, BSS/WSS based CART and even
UTISP based CART [34]. Among these methods, k-NN and CART uses
the information of all genes variable and the redundant parts of the
data lead to lower the prediction accuracy of these model. However
Qin Yu et al. [34], increased the prediction power of CART by its combi-
nation with novel variable selection, which has been named unimodal
transform of variables selected by interval segmentation purity; UTISP.
As it is shown in Table 6, this method could not produce prediction ac-
curacy higher than GA-LDA based on dimension reduction because the
latter method not only use the information from all cluster of variables
but also use the included information in the genes that are correlated
with these selected genes variable.Table 7
Statistical parameters of the GA-LDA based dimension reduction models obtained from differe
Number of segments
(Kohonen nodes)
NSPC
a NERcalb NERvalc
4 (2 × 2) 6 1.0 0.93
9 (3 × 3) 6 1.0 0.93
16 (4 × 4) 5 1.0 0.98
25 (5 × 5) 6 0.99 0.97
36 (6 × 6) 6 1.0 0.97
49 (7 × 7) 6 1.0 0.97
64 (8 × 8) 5 0.98 0.96
a Number of selected PCs.
b Not error rate for calibration set.
c Not error rate for validation.
d Not error rate for prediction set.
e Not error rate based on repeated double cross-validation for calibration set.
f Not error rate based on repeated double cross-validation for validation set.
g Not error rate based on repeated double cross-validation for prediction set.5. Biological signiﬁcance of selected gene
As was mentioned the selected important genes of Leukemia data
set are listed in Table 4. To evaluate the performance of these selected
genes in cancer classiﬁcation, we compared themwith themost impor-
tant genes reported by Golub et al. [28]. This comparison indicates that
there is a good consistencywith experimental evidences of gene expres-
sions for Leukemia data set. Although out of 23 genes selected by our
method, 12 genes were also selected by Golub et al. [28], the remaining
genes have also relevance to this cancer. The role of several biologically
signiﬁcant genes can be explained because some of them code for
proteins which play important roles in Leukemia such as Macmarcks
gene, where tumor necrosis factor-alpha rapidly stimulates Macmarcks
gene transcription in human promyelocytic Leukemia cells [35]. The
ZYX gene: Zyxin encodes a LIM domain protein localized at focal
contacts in adherent erythroleukemia cells [36]. The CCND3 gene: A
51-bp deletion was detected in CCND3 in a patient with normal karyo-
type acute myeloid Leukemia [37].
On the other hand, those genes which were not presented by Golub
[28] such as NM23 have been reported by other researchers [38]. Many
researchers have postulated that the NM23 gene family is related to
Leukemia such as NM23-H1 [39–41]. It sounds that the other selected
genes by our method also present signiﬁcant role in cancer, like PKM2
gene which is generally expressed in tumor cells and its presence in
plasma can be used as a diagnostic marker. Its role in tumor cells may
contribute to the Warburg effect in cancer, where cells up regulatent clusters (nodes of the Kohonen network): SRBCT data set.
NERpred NERrdCV,cale NERrdCV,valf NERrdCV,preg
0.97 1.0 0.95 0.98
0.88 0.98 0.95 0.91
0.85 0.99 0.98 0.89
0.83 0.98 0.95 0.85
0.77 0.97 0.94 0.80
0.75 0.97 0.91 0.77
0.75 0.97 0.91 0.72
Fig. 4. 3-Dimensional discriminant function (DF) plot (DF1 ×DF2×DF3) using GA-LDA based on dimension reduction technique on SRBCT data set. Themarkers are the same as described
in Fig. 3.
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[42]. In addition, Leukocyte surface antigen CD53 is another selected
gene. CD53 is a member of the tetraspanin family of hydrophobic
membrane-spanning proteins. High levels of CD53 expression is found
on different cancers, such as B-cell Leukemia and lymphomas, suggest-
ing it may contribute to increased survival of the tumor cells [43].
HMG-I acts as an oncogene and it is suggested that it contributes to
the pathogenesis of Leukemia and other cancers with elevated
HMG-I expression [44]. Finally, SAT gene associates with white blood
cell count in myeloid Leukemia [45]. Important issue that should be
mentioned in the case of Leukemia data [28], is that less useful informa-
tion can be obtained. This is probably due to the fact that, not possible to
construct a perfect prediction based on using the training data. On the
other hand, test data set of Leukemia seems to be very different from
the data set used to model development part [46].
Similarly, the same ﬁnding has been obtained for SRBCT. The select-
ed genes are reported in Supplementary Table S5. In this case, there is a
high consensus between our selected genes and that reported by Khan
[29] and all 55 selected genes have been also presented by the method
of Khan [29]. In accordance with the report of Khan [29], all these iden-
tiﬁed genes are related to tumor histogenesis or associatedwith a single
cancer type. For example MIC2, is currently used to diagnose EWS. In
addition, IGF2 and FGFR4 are two genes which are highly expressed
only in RMS and related to myogenesis.
6. Conclusion
In the present study, clustering of variable concept has been used in
gene expression data analysis for cancer detection. In this algorithm, the
entire variable is divided into different clusters using unsupervised
pattern recognition. The local useful PCs extracted from each cluster of
the original variable can be collected in a matrix and this can provide
a signiﬁcant reduction in the complexity of collinear high-dimensional
data. Finally reduced data set can be treated with the proposed variable
selection methods. The obtained results, demonstrate that it is possible
to split the information in the linear discriminant into informative and
redundant ones. The performance of this method has been validated
by analysis of the two public gene expression data sets (Leukemia and
SRBCT). The results indicate that, for such high-dimensional data, the
data reduction plays a more signiﬁcant role for variable selection and
classiﬁcation method in achieving reasonable results.
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